Bishoy Faltas is the recipient of the CTSC Pilot Award

Weill Cornell CTSC shared a post on X:

“Congratulations to CTSC Pilot Awardee Dr. Bishoy Faltas on his recent breakthrough study published in Nature titled “The Interplay of Mutagenesis and ecDNA Shapes Urothelial Cancer Evolution.”

The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution

Authors: Duy D. Nguyen, William F. Hooper, Weisi Liu, Timothy R. Chu, Heather Geiger, Jennifer M. Shelton, Minita Shah, Zoe R. Goldstein, Lara Winterkorn, Adrienne Helland, Michael Sigouros, Jyothi Manohar, Jenna Moyer, Majd Al Assaad, Alissa Semaan, Sandra Cohen, Florencia Madorsky Rowdo, David Wilkes, Mohamed Osman, Rahul R. Singh, Andrea Sboner, Henkel L. Valentine, Phillip Abbosh, Scott T. Tagawa, David M. Nanus, Jones T. Nauseef, Cora N. Sternberg, Ana M. Molina, Douglas Scherr, Giorgio Inghirami, Juan Miguel Mosquera, Olivier Elemento, Nicolas Robine & Bishoy M. Faltas.

Dr. Bishoy Morris Faltas is the Chief Research Officer at the Englander Institute for Precision Medicine and an Associate Professor of Medicine and Cell and Developmental Biology at Weill Cornell Medicine. He also serves as the Director of Bladder Cancer Research at the Englander Institute for Precision Medicine and is an Associate Attending at NewYork-Presbyterian Hospital. A member of the Editorial Board of The ASCO Post, Dr. Faltas is focused on studying bladder cancer, a disease for which there are currently no uniformly curative therapies.